個股熱度排行 | 2月25日港股收盤
根據uSMART輿情監測數據,25日港股交易時段,市場關注指數最高的5只股票是網易-S、匯豐控股、百威亞太、藥明生物、電訊盈科。2月25日—港股關注排行TOP5
網易-S
關注度第一爲網易-S,該股今日收盤上漲1.32%,報於146.30港元。近5個交易日累計下跌6.64%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
大和維持網易218港元目標價 重申“買入”觀點
一文綜合券商於網易公佈業績最新目標價及觀點
匯豐控股
關注度第二爲匯豐控股,該股今日收盤下跌2.49%,報於54.75港元。近5個交易日累計下跌5.60%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:
港股恆指直線跳水倒跌0.5% 匯豐控股大跌5%領跌藍籌
匯豐005一度跌近半成低見53.2元 短炒夠鍾散水、中長線入場撈貨時機?
百威亞太
關注度第三爲百威亞太,該股今日收盤上漲3.76%,報於24.85港元。近5個交易日累計上漲7.58%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
摩通上調百威亞太目標價至31.8元 評級「增持」
中金:維持百威亞太“跑贏行業”評級 目標價26.8港元
藥明生物
關注度第四爲藥明生物,該股今日收盤上漲3.97%,報於64.20港元。近5個交易日累計上漲2.64%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
CRO概念股全線上揚 藥明康德漲6.48%
港股成交額TOP20:醫藥股王者歸來?藥明生物漲超4% 成交額超17億港元
電訊盈科
關注度第五爲電訊盈科,該股今日收盤上漲5.83%,報於4.36港元。近5個交易日累計上漲3.81%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
匯豐研究上調電訊盈科至“買入”評級 升目標價12.5%至5.4港元
電訊盈科漲超4% 去年扭虧爲盈10.39億元
此外,監測期內有4只股票的輿情出現大扭轉,意味着在消息面上出現了可能影響公司股價趨勢的事件或者轉折。
2月25日—港股輿情轉折預警
金蝶國際
金蝶國際輿情扭轉指數達99,目前輿情方向爲利好,表明公司出現了被投資者視作較大利好的消息。
其中較被市場關注的消息有:
金蝶國際漲6.65% 小摩給予其增持評級
利好疊加 金蝶國際反彈超7%
藥明生物
藥明生物輿情扭轉指數達97,目前輿情方向爲利好,表明公司出現了被投資者視作較大利好的消息。
其中較被市場關注的消息有:
CRO概念股全線上揚 藥明康德漲6.48%
港股成交額TOP20:醫藥股王者歸來?藥明生物漲超4% 成交額超17億港元
電訊盈科
電訊盈科輿情扭轉指數達96,目前輿情方向爲利好,表明公司出現了被投資者視作較大利好的消息。
其中較被市場關注的消息有:
匯豐研究上調電訊盈科至“買入”評級 升目標價12.5%至5.4港元
電訊盈科漲超4% 去年扭虧爲盈10.39億元
匯豐控股
匯豐控股輿情扭轉指數達95,目前輿情方向爲利空,表明公司出現了被投資者視作較大利空的消息。
其中較被市場關注的消息有:
港股恆指直線跳水倒跌0.5% 匯豐控股大跌5%領跌藍籌
匯豐005一度跌近半成低見53.2元 短炒夠鍾散水、中長線入場撈貨時機?
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.